Highlights Hualan Group Co., Ltd.

Equities

301027

CNE100004MH7

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-16 EDT			5-day change	1st Jan Change
8.96 ^CNY	+3.70%		+6.54%	-28.38%

05-16	Hualan Biological Engineering's Blood Centers Get License to Operate	MT
04-23	Hualan Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hualan Biological Engineering's Blood Centers Get License to Operate	05-16	MT
Hualan Group Co., Ltd. Proposes Final Dividend for 2023	04-23	CI
Hualan Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-23	CI
Hualan Biological Engineering's Profit Rises 38%; Tops EPS, Revenue Estimates	04-01	MT
Hualan Biological Engineering Obtains Blood Collection License	02-02	MT
Hualan Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Hualan Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Hualan Biological Engineering's Plasma Station Gets Permit to Collect Blood	23-08-16	MT
Hualan Group Unit Secures Construction Enterprise Qualification Certificate	23-08-04	MT
Hualan Biological Engineering's Unit Gets Nod to Trial Antibody Injection	23-07-07	MT
Hualan Group Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 20, 2023	23-06-14	CI
Hualan Biological Engineering Obtains Blood Plasma Collection License	23-05-31	MT
Hualan Group Co., Ltd. Approves Cash Dividend for the Year 2022	23-05-17	CI
Hualan Biological Engineering's Unit Gets Nod for Trial of Tumor Drug	23-05-05	MT
Hualan Group Co., Ltd. Proposes Cash Final Dividend for 2022	23-04-25	CI
Hualan Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Hualan Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24	CI
Hualan Biological Bacterin to Return to Profit in Q1	23-04-10	MT
Hualan Biological Bacterin Gets Certification for Tetanus Vaccine	23-02-28	MT
Hualan Biological Bacterin Registers Freeze-Dried Human Rabies Vaccine	23-02-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hualan Group Co., Ltd.

Equities

301027

CNE100004MH7

Highlights

Filters